The Vanguard Group Discloses Interests in Mural Oncology plc

The Vanguard Group, Inc. has released an opening position disclosure under Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure pertains to Mural Oncology plc and details various interests and short positions in relevant securities.

As of April 22, 2025, Vanguard controls 772,615 ordinary shares of Mural Oncology, amounting to 4.47%. No interests or positions in cash-settled derivatives or stock-settled derivatives are currently disclosed. The announcement includes a minor purchase transaction of 54 ordinary shares at 2.72 USD each.

No indemnity, option arrangements, or any significant agreements impacting the securities are reported. Moreover, Vanguard does not disclose any arrangements related to options or derivatives, nor are there attachments accompanying the form.